Top Buy
| Wertpapier | Buy | Sell | Buy (1M) ▲ | Sell (1M) | Kurs | Kursziel | Potential |
|---|---|---|---|---|---|---|---|
| Intellia Therapeutics Inc | 15 | 1 | 2 | 0 | 22,76 € | 60,53 € | 165,94 % |
| Rigel Pharmaceutical Inc. | 12 | 0 | 2 | 0 | 0,84 € | 13,78 € | 1543,29 % |
| Codexis Inc. | 7 | 2 | 2 | 0 | 2,68 € | 8,36 € | 212,23 % |
| Natural Alternat. | 19 | 1 | 2 | 0 | 5,65 € | - | - |
| Addus Homecare Corp. | 17 | 1 | 3 | 0 | 108,00 € | 108,73 € | 0,67 % |
| Corcept Therapeutics Inc. | 14 | 0 | 3 | 0 | 26,23 € | 36,87 € | 40,56 % |
| Catalyst Pharmaceutical Partners Inc | 14 | 0 | 3 | 0 | 13,95 € | 24,13 € | 73,06 % |
| Intra-Cellular Therapies Inc. | 28 | 0 | 4 | 0 | 70,50 € | 79,68 € | 13,02 % |
| Verastem Inc. | 11 | 0 | 4 | 0 | 3,12 € | 19,20 € | 515,38 % |
| Geron Corp. | 17 | 0 | 5 | 0 | 4,19 € | 5,58 € | 33,37 % |
| Cytokinetics Inc. | 33 | 1 | 7 | 0 | 48,40 € | 83,56 € | 72,65 % |
| G1 Therapeutics | 22 | 2 | 8 | 1 | 2,39 € | 10,54 € | 341,15 % |
| Insmed Inc. | 30 | 1 | 12 | 1 | 60,50 € | 63,62 € | 5,16 % |